What is Rinvoq?
Rinvoq is the brand name for the oral systemic treatment upadacitinib. Different oral systemic treatments work in different ways to reduce symptoms of psoriatic disease. Newer oral systemic treatments, such as Rinvoq, work similarly to biologics by targeting specific parts of the immune system to reduce symptoms and inflammation.
How Is It Used?
Rinvoq is a pill (15mg) that is taken once per day.
People Who Can Take Rinvoq
The U.S. Food and Drug Administration (FDA) approved Rinvoq to treat adults living with psoriatic arthritis in 2021. Rinvoq is also approved to treat conditions other than psoriatic arthritis including rheumatoid arthritis.
What Are the Risks?
Rinvoq may increase your chance of:
- Serious infections
- Cancer
- Major cardiovascular events such as heart attack or stroke
- Blood clots
- Tears in the stomach or intestines
Common Side Effects
In clinical trials, the most common side effects were upper respiratory infections, nausea, cough, fever, and acne.
Using Rinvoq With Other Treatments
Rinvoq may not be safe to use with certain prescriptions including JAK inhibitors, biologic DMARDs, or with potent immunosuppressants such as azathioprine and cyclosporine, or certain over-the-counter (OTC) medications. Talk to your health care provider about whether using any other treatments with Rinvoq is right for you.
